Dopamine < Dopamine Agents < Dopamine Agonists

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 137.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000277 (2015)	Doris E. Payer ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau	[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
000334 (2015)	Eugene V. Mosharov ; Anders Borgkvist ; David Sulzer	Presynaptic effects of levodopa and their possible role in dyskinesia.
000360 (2015)	Oscar S. Gershanik	Improving L-dopa therapy: the development of enzyme inhibitors.
000365 (2015)	Marjan Jahanshahi ; Ignacio Obeso ; Christelle Baunez ; Manuel Alegre ; Paul Krack	Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity.
000394 (2014)	Alice Laudisio ; Davide L. Vetrano ; Eleonora Meloni ; Diego Ricciardi ; Francesco Franceschi ; Anna Rita Bentivoglio ; Roberto Bernabei ; Giuseppe Zuccalà	Dopaminergic agents and nutritional status in Parkinson's disease.
000399 (2014)	Silke Appel-Cresswell ; Ali H. Rajput ; Vesna Sossi ; Christina Thompson ; Vanessa Silva ; Jessamyn Mckenzie ; Katherine Dinelle ; Siobhan E. Mccormick ; Carles Vilari O-Güell ; A Jon Stoessl ; Dennis W. Dickson ; Chris A. Robinson ; Matthew J. Farrer ; Alex Rajput	Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism.
000749 (2013)	David E. Vaillancourt ; Daniel Schonfeld ; Youngbin Kwak ; Nicolaas I. Bohnen ; Rachael Seidler	Dopamine overdose hypothesis: evidence and clinical implications.
000801 (2013)	Joseph Jankovic	Medical treatment of dystonia.
000845 (2013)	Ralf Reilmann	The pridopidine paradox in Huntington's disease.
000856 (2013)	Aikaterina Angeli ; Niccolo E. Mencacci ; Raquel Duran ; Iciar Aviles-Olmos ; Zinovia Kefalopoulou ; Joseph Candelario ; Sarah Rusbridge ; Jennifer Foley ; Priyanka Pradhan ; Marjan Jahanshahi ; Ludvic Zrinzo ; Marwan Hariz ; Nicholas W. Wood ; John Hardy ; Patricia Limousin ; Tom Foltynie	Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation.
000873 (2013)	Erwan Bézard ; C Warren Olanow ; José A. Obeso	Levodopa-induced dyskinesias in the absence of nigrostriatal degeneration.
000A09 (2013)		A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease.
000A56 (2013)	Pauline Belujon ; Anthony A. Grace	L-dopa treatment duration versus Parkinson's disease progression: the dorsal-ventral divide.
000A85 (2013)	Roser Pons ; Dimitris Syrengelas ; Sotiris Youroukos ; Irene Orfanou ; Arqirios Dinopoulos ; Bru Cormand ; Aida Ormazabal ; Angels Garzía-Cazorla ; Mercedes Serrano ; Rafael Artuch	Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency.
000A93 (2013)	Erwan Bezard ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta	Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
000B64 (2013)	Alex A. Macdonald ; Oury Monchi ; Ken N. Seergobin ; Hooman Ganjavi ; Ruzbeh Tamjeedi ; Penny A. Macdonald	Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
000C46 (2012)	Jessie Theuns ; David Crosiers ; Luc Debaene ; Karen Nuytemans ; Bram Meeus ; Kristel Sleegers ; Dirk Goossens ; Ellen Corsmit ; Ellen Elinck ; Karin Peeters ; Maria Mattheijssens ; Barbara Pickut ; Jurgen Del-Favero ; Sebastiaan Engelborghs ; Peter Paul De Deyn ; Patrick Cras ; Christine Van Broeckhoven	Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystonia.
000D81 (2012)	Katrina L. Paumier ; Andrew D. Siderowf ; Peggy Auinger ; David Oakes ; Lalitha Madhavan ; Alberto J. Espay ; Fredy J. Revilla ; Timothy J. Collier	Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease.
000E53 (2012)	Robert Iansek ; Mary Danoudis	Oral formulations of L-dopa and continuous dopaminergic stimulation.
000F23 (2011)	Alfonso Fasano ; Alessandro Di Matteo ; Carmine Vitale ; Giovanna Squintani ; Laura Ferigo ; Federica Bombieri ; Gabriella Santangelo ; Marianna Amboni ; Paolo Barone ; Michele Tinazzi	Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy.
000F95 (2011)	Jose A. Obeso ; Warren Olanow	Continuing efforts to obtain continuous delivery of levodopa.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Dopamine Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Dopamine Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Dopamine Agents
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024